BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $333,000 | +2.5% | 310,000 | 0.0% | 0.00% | – |
| Q3 2020 | $325,000 | -97.0% | 310,000 | -96.6% | 0.00% | -100.0% |
| Q2 2020 | $10,999,000 | +949.5% | 9,000,000 | +800.0% | 0.00% | – |
| Q1 2020 | $1,048,000 | -0.8% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,056,000 | -2.3% | 1,000,000 | -9.1% | 0.00% | – |
| Q3 2019 | $1,081,000 | -38.8% | 1,100,000 | -35.3% | 0.00% | – |
| Q2 2019 | $1,765,000 | +1.3% | 1,700,000 | -0.2% | 0.00% | – |
| Q1 2019 | $1,742,000 | +39.0% | 1,703,000 | +35.2% | 0.00% | – |
| Q4 2018 | $1,253,000 | -87.6% | 1,260,000 | -86.7% | 0.00% | -100.0% |
| Q3 2018 | $10,125,000 | -3.6% | 9,500,000 | -8.7% | 0.00% | 0.0% |
| Q2 2018 | $10,506,000 | -16.2% | 10,400,000 | -22.1% | 0.00% | 0.0% |
| Q1 2018 | $12,532,000 | -19.1% | 13,350,000 | -14.1% | 0.00% | -50.0% |
| Q4 2017 | $15,492,000 | +40.3% | 15,550,000 | +42.7% | 0.00% | +100.0% |
| Q3 2017 | $11,043,000 | – | 10,900,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
| Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
| Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
| Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
| LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
| Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
| Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
| CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
| Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |